Effects of topical nipradilol, a β blocking agent with α blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans

British Journal of Ophthalmology

Volumn 84, Issue 3, 2000, Pages 293-299

  Kanno, Mikiko ^a   Araie, Makoto ^a   Koibuchi, Hiroshi ^b   Masuda, Kanjiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JR Tokyo General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; NIPRADILOL; TIMOLOL;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRY EYE; EYE IRRITATION; FEMALE; FOREIGN BODY REACTION; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MATHEMATICAL ANALYSIS; MEASUREMENT; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLERA; TACHYPHYLAXIS; UVEA; VENOUS PRESSURE; VISUAL IMPAIRMENT;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROPANOLAMINES; TIMOLOL;

EID: 0034019026     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.3.293     Document Type: Article

References (27)

1. Uchida Y, Nakamura M, Shimizu S, et al. Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran(K-351), a new antihypertensive agent. Arch Int Pharmacodyn 1983;262:132-49.
2. Ohhira A, Wada Y, Fujii M, et al. Effects of nipradilol (K-351) on alpha-adrenocepter mediated responses in various isolated tissues. Arch Int Pharmacodyn 1985;278: 61-71.
3. Shirasawa Y, Fujii M, Nakamura M. Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine. Jap J Pharmacol 1985;39:77-82.
4. Furuta Y, Matuoka A, Sano H, et al. Effect of nipradilol on ambulatory blood pressure of essential hypertensive patients. Ther Res 1994;15:379-85.
5. Serle JB, Stein AJ, Podos SM, et al. Corynanthine and aqueous humor dynamics in rabbits and monkeys. Arch Ophthalmol 1984;102:1385-8.
6. Kageyama M, Nishimura K, Matsugi T, et al. Mechanisms for ocular hypotensive effects of bunazosin hydrochloride in albino rabbits. Folia Ophthalmol Jpn 1995;46:1066-70.
7. Oshika T, Araie M, Sugiyama T, et al. Effect of bunazosin hydrochloride on intraocular pressure and and aqueous humor dynamics in normotensive human eyes. Arch Ophthalmol 1991;109:1569-74.
8. Taniguchi T, Deguchi T, Ogawa T, et al. Effects of amosulalol hydrochloride on intraocular pressure and aqueous humor dynamics in the rabbit eye. J Jpn Ophthalmol Soc 1996;100:279-83.
9. Smith BR, Murray DL, Leopold IH. Influence of topically applied prazosin on the intraocular pressure of experimental animals. Arch Ophthalmol 1979;97:1933-6.
10. Krupin T, Feitl M, Becker B. Effects of prazosin on aqueous humor dynamics in rabbits. Arch Ophthalmol 1980;98: 1639-42.
11. Iuglio N. Ocular effects of topical application of dapiprazole in man. Glaucoma 1984;6:110-6.
12. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther 1992;260:956-65.
13. Schuman JS, Erickson K, Nathanson JA. Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 1994;58:99-105.
14. Azuma I, Kitazawa Y, Tsukahara S, et al. Long-term study of bunazosin hydrochloride ophthalmic solution in primary open-angle glaucoma and ocular hypertension. J Eye 1994; 11:631-5.
15. Kanno M, Araie M, Tomita K, et al. Effects of topical nipradilol, a β-blocking agent with α-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Invest Ophthalmol Vis Sci 1998;39: 736-43.
16. Oshika T, Araie M. Time course of changes in aqueous protein concentration and flow rate after oral acetazolamide. Invest Ophthalmol Vis Sci 1990;31:527-34.
17. Tomilinson A, Leighton DA. Ocular dimensions and the heredity of open-angle glaucoma. Br J Ophthalmol 1974;58: 68-74.
18. Lam AKC, Douthwaite WA. A pilot study on the measurement of central posterior corneal radius in Hong Kong Chinese using Purkinje image technique. Ophthalmol Physiol Opt 1997;17:68-74.
19. Jones RF, Maurice DM. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 1966; 5:208-20.
20. Mori M, Araie M. A simple methods of determining the time course of timolol's effects on aqueous flow in humans. Arch Ophthalmol 1991;109:1099-103.
21. Mori M, Araie M. Relationship between fluorescence intensity in the cornea as measured with Fluorotron master and actual fluorescein concentration. Folia Ophthalmol Jpn 1990;41:2204-7.
22. Brubaker RF. Clinical evaluation of the circulation of aqueous humor. In: Duane TD, Jaeger EA, eds. Clinical opthalmology, Philadelphia: Harper and Row, 1986;3:1-11.
23. Scriabine A, Torchiana ML, Stavoriski JM, et al. Some cardiovascular effects of timolol, a new β-adrenergic blocking agent. Arch Int Pharmacodyn 1973;205:76-93.
24. Zimmerman TJ, Kooner KS, Kandarakis AS, et al. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984;102:551-3.
25. Hayashi M, Yablonski ME, Novack GD. Trabecular outflow facility determined by fluorophotometry in human subjects. Exp Eye Res 1989;48:621-5.
26. Sakurai M, Araie M, Oshika T, et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1991;35:156-65.
27. Azuma I. Usefulness of alpha-1 antagonist in glaucoma therapy. Folia Ophthalmol Jpn 1991;42:710-14.